RecruitingNCT06522347

Mycobacteria Registry Study: Prospective Observational Study in Austria


Sponsor

Ludwig Boltzmann Institute for Lung Health

Enrollment

1,000 participants

Start Date

Jan 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this non-interventional registry study is to systematically collect epidemiological and clinical data throughout the treatment course to learn about effectiveness of treatments. We will document the natural course of therapy without additional interventions. The main question to answer is: What are the risk factors for mortality due to infection with Mycobacteria tuberculosis (TB) or Nontuberculous mycobacteria (NTM) in Austria? Data from participants already receiving treatment as part of their regular medical care for TB or NTM infections will be collected.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • patients diagnosed with Mycobacterium tuberculosis or non-tuberculous mycobacteria infection
  • individuals aged 18 years or older
  • written informed consent

Exclusion Criteria1

  • to not comprehend and rightfully judge participation

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(3)

Klinik Hietzing

Vienna, Austria

Klinik Penzing

Vienna, Austria

Ludwig Boltzmann Institut for Lung Health

Vienna, Austria

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06522347


Related Trials